Announcements Trials
Browse Landscape

Phase

Phase 2 16Phase NA 8Phase EARLY_PHASE1 6Phase 4 4Phase 1/2 3Phase 1 3Phase 3 1Phase 2/3 1

Status

Completed 2Recruiting 1

Sponsor Class

INDUSTRY 7979OTHER 6861NIH 1173NETWORK 185OTHER_GOV 82FED 18UNKNOWN 15INDIV 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 1Gynecologic 1Dermatologic 1

Conditions

Uterine Neoplasms 1Melanoma 1Leiomyomatosis 1Leiomyoma 1Advanced Solid Cancer 1

Interventions

pembrolizumab 1keyhole-limpet hemocyanin 1Peptides 1Monatide (IMS 3015) 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × INDIV × Interventional × Clear all
NCT07123415 2025-11-19

A Phase 1 Study of APX-343A as Monotherapy or in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

Aptabio Therapeutics, Inc.

Phase 1 Recruiting
110 enrolled
Other solid neoplasm

Advanced Solid Cancer

NCT00124124 2015-02-13

Comparison of Dendritic Cells Versus Montanide as Adjuvants in a Melanoma Vaccine

Bhardwaj, Nina, M.D.

Phase 1 Completed
50 enrolled
Dermatologic

Melanoma

NCT00361036 2011-04-18

Comparison Study in the Treatment of Uterine Fibroids Uterine Fibroid Embolization Using BeadBlockâ„¢ Embolic Agent

Worthington-Kirsch, Robert L., M.D.

Phase 1 Completed
44 enrolled
Gynecologic

Leiomyoma, Uterine Neoplasms, Leiomyomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡